XML 28 R17.htm IDEA: XBRL DOCUMENT v3.8.0.1
12. Segments
9 Months Ended
Dec. 31, 2017
Segment Reporting [Abstract]  
Segments

We operate our businesses principally through two reportable segments: Aethlon, which represents our therapeutic business activities, and ESI, which represents our diagnostic business activities. Our reportable segments have been determined based on the nature of the potential products being developed. We record discrete financial information for ESI and our chief operating decision maker reviews ESI’s operating results in order to make decisions about resources to be allocated to the ESI segment and to assess its performance.

 

Aethlon’s revenue is generated primarily from government contracts to date and ESI does not yet have any revenues. We have not included any allocation of corporate overhead to the ESI segment.

 

The following tables set forth certain information regarding our segments:

 

   Nine Months Ended December 31, 
   2017   2016 
Revenues:        
Aethlon  $74,813   $392,073 
ESI        
Total Revenues  $74,813   $392,073 
           
Operating Losses:          
Aethlon  $(3,495,189)  $(4,478,631)
ESI   (64,860)   (115,443)
Total Operating Loss  $(3,560,049)  $(4,594,074)
           
Net Losses:          
Aethlon  $(4,308,807)  $(5,497,978)
ESI   (64,860)   (115,443)
Net Loss Before Non-Controlling Interests  $(4,373,667)  $(5,613,421)
           
Cash:          
Aethlon  $5,610,061   $625,531 
ESI   738    3,084 
Total Cash  $5,610,799   $628,615 
           
Total Assets:          
Aethlon  $5,745,031   $752,578 
ESI   5,723    37,019 
Total Assets  $5,750,754   $789,597 
           
Capital Expenditures:          
Aethlon  $23,705   $2,961 
ESI        
Capital Expenditures  $23,705   $2,961 
           
Depreciation and Amortization:          
Aethlon  $27,402   $16,322 
ESI       10,043 
Total Depreciation and Amortization  $27,402   $26,365 
           
Interest Expense:          
Aethlon  $(306,495)  $(115,308)
ESI        
Total Interest Expense  $(306,495)  $(115,308)